Atlas Trials

Evaluation of the Respimat Inhaler vs. a HFA MDI Using Berodual in Patients With COPD With Poor MDI Technique.

Clinical trial NCT00267917 · COMPLETED

Trial details

NCT number
NCT00267917
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Pulmonary Disease, Chronic ObstructiveAsthma
Start date
2006-01-17
Primary completion
2006-02-27
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.